Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: a tale of misnomers, controversy and the unresolved
Abstract The World Health Organization classification and definition of “myeloid sarcoma” is
imprecise and misleading. A more accurate term is “extramedullary acute myeloid leukemia …
imprecise and misleading. A more accurate term is “extramedullary acute myeloid leukemia …
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy that
can involve the bone marrow, peripheral blood, skin, lymph nodes, and the central nervous …
can involve the bone marrow, peripheral blood, skin, lymph nodes, and the central nervous …
Ultraviolet radiation shapes dendritic cell leukaemia transformation in the skin
Tumours most often arise from progression of precursor clones within a single anatomical
niche. In the bone marrow, clonal progenitors can undergo malignant transformation to …
niche. In the bone marrow, clonal progenitors can undergo malignant transformation to …
Sex-Biased ZRSR2 Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive leukemia of
plasmacytoid dendritic cells (pDC). BPDCN occurs at least three times more frequently in …
plasmacytoid dendritic cells (pDC). BPDCN occurs at least three times more frequently in …
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need
N Pemmaraju, H Kantarjian, K Sweet, E Wang… - Blood, 2023 - ashpublications.org
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy
with historically poor outcomes and no worldwide consensus treatment approach. Unique …
with historically poor outcomes and no worldwide consensus treatment approach. Unique …
Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape
L Zalmaï, PJ Viailly, S Biichle, M Cheok… - …, 2020 - pmc.ncbi.nlm.nih.gov
Neoplasms involving plasmacytoid dendritic cells (pDC) include blastic pDC neoplasms
(BPDCN) and other pDC proliferations, where pDC are associated with myeloid …
(BPDCN) and other pDC proliferations, where pDC are associated with myeloid …
Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia
Plasmacytoid dendritic cells (pDCs) are the principal natural type I interferon–producing
dendritic cells. Neoplastic expansion of pDCs and pDC precursors leads to blastic …
dendritic cells. Neoplastic expansion of pDCs and pDC precursors leads to blastic …
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy
with a poor prognosis and considered incurable with conventional chemotherapy. Small …
with a poor prognosis and considered incurable with conventional chemotherapy. Small …
Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis
F Renosi, A Roggy, A Giguelay, L Soret… - Blood …, 2021 - ashpublications.org
Oncogenesis and ontogeny of blastic plasmacytoid dendritic cell neoplasm (BPDCN) remain
uncertain, between canonical plasmacytoid dendritic cells (pDCs) and AXL+ SIGLEC6+ DCs …
uncertain, between canonical plasmacytoid dendritic cells (pDCs) and AXL+ SIGLEC6+ DCs …
Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a ten-color flow cytometric panel for initial workup …
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematopoietic neoplasm
whose immunophenotype remains incompletely characterized, particularly with regards to …
whose immunophenotype remains incompletely characterized, particularly with regards to …